A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Takeda
Takeda
Tempus AI
NantCell, Inc.
HiberCell, Inc.
Icahn School of Medicine at Mount Sinai
MacroGenics
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Stanford University
Calando Pharmaceuticals
Vanderbilt-Ingram Cancer Center